Fukasaku Small Pupil Irrigating Nucleus Chopper

Products	Fukasaku Small Pupil Irrigating Nucleus Chopper
Company	Katena Products, Inc.
Item	Fukasaku Small Pupil Irrigating Nucleus Chopper
Features
Description	Small pupil irrigating nucleus chopper, wedge-shaped inferior edge with, blunt tip and front notch, for engaging the iris, 0.6 mm dual sideports, 20 gauge.
Info	Katena Products, Inc. Customer Service: (800) 225-1195 Web site: http://www.katena.com/

TAG: Fukasaku Small Pupil Irrigating Nucleus Chopper

Medicine Products:

Hydrophobic Tubing Filter (green-tinted PVC)Clear-Therm Mini™ + Micro Mount with Flextube Clear-Therm®Filta-Therm® with CO₂ Port

Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2 Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2 Health News:Molecule Discovery Might Help ALS Patients 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 3 Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2

[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting [0] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health [0] Molecule Discovery Might Help ALS Patients [0] Swine Flu Has Infected 1 in 6 Americans: CDC [0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics

Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.Smokers Will Stop for Their Pet's Sake Diseased Heart Valve Replaced Through Small Chest Incision The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY

Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3 Within3 Expands into Mobile Applications 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 1 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 3 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 4 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 1 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 2 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 3 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 4

[0] ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)[0] Boston Scientific Announces Pricing of $2 Billion of Senior Notes [0] Within3 Expands into Mobile Applications